Additional file 2: of Measuring financial protection against catastrophic health expenditures: methodological challenges for global monitoring

Technical note on the application of restricted dominance methods to catastrophic health expenditures. (DOCX 21 kb

Additional file 1: of Measuring financial protection against catastrophic health expenditures: methodological challenges for global monitoring

List of surveys. (DOCX 17 kb

Examples of the three main analytical approaches and two possible measures for analyzing health aid to specific areas.

a<p>Additional data sources used to complement the CRS.</p>b<p>Analyses based on commitments; a limited comparison of disbursement and commitment data conducted.</p>c<p>Not clearly specified whether disbursement or commitment data used, but disbursements are suggested.</p>d<p>Commitments and disbursements used to estimate disbursements for analyses.</p>e<p>Analysis based on disbursement data except for the World Bank, which only reported commitments.</p

Estimates for the value of aid benefitting newborns in context.

<p>The figure shows several options for estimating how much aid is benefitting newborns in the context of overall aid to the health and emergency response sectors. As a lower bound of estimation of the value of aid benefitting newborns, the dashed and solid blue lines reflect the value of projects exclusively benefitting newborns. The green lines reflect the value of aid disbursements whose descriptions mention a newborn search term in each of the two databases. As upper bounds of estimation of the value of aid benefitting newborns, the solid peach, turquoise, and purple lines reflect estimates of the total value of aid for MNH or for MNCH. The orange and dark red lines indicate the value of aid to the health and population sectors as a whole, with the dark red also including humanitarian aid. Solid lines reflect estimates based on donors who reported in all years, while dashed lines reflect estimates based on all available data, including donors who may not have reported in all years. DAH, development assistance for health.</p

Final list of search terms identifying projects that benefit newborns ranked by number of additional records identified.

<p>?, single character wildcard.</p><p>_, used to highlight the presence of a blank character.</p

The value of records mentioning newborn search terms, 2002–2010.

<p>The figure presents the value of aid identified by the search strategy in constant 2010 US. Data are disaggregated by (1) whether the donor reported to the CRS in all 9 y (shown in purple) or in fewer than 9 y (shown in turquoise); (2) whether the funding exclusively benefits newborns or also benefits other population groups; and (3) whether the funding supported research or non-research (i.e., programme or project implementation or advocacy) activities. The figure demonstrates that a large majority of aid including a newborn search term was provided for non-research activities that also benefitted other population groups by donors who reported in all years. In 2009 and 2010, the Gates Foundation, which only reported in those years, provided significant funds for research. The following donors (shown in turquoise) mentioned newborns in at least one disbursement but reported for only some of the 9 y: The Bill & Melinda Gates Foundation (2009–2010), Denmark (2003–2010), Finland (2002–2003, 2006–2010), the GAVI Alliance (2007–2010), Korea (2006–2010), the Organization of the Petroleum Exporting Countries' Fund for International Development (OFID, 2009–2010), and the World Health Organization (2009–2010). The Global Fund reported for 2003–2010, but has been included amongst donors who reported for all years as their publicly available data indicate that their total disbursements in 2002 constituted less than US1 million and was provided to Ghana for HIV and tuberculosis.</p

Estimates of the value of aid including newborn search terms and exclusively benefitting newborns.

<p>The figure presents the same data as in <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001332#pmed-1001332-g002" target="_blank">Figure 2</a> except in that it excludes the estimates of aid for MNCH and MNH, and is on a 7.5-fold smaller scale to enable closer examination of estimates specific to newborns.</p

Final list of search terms identifying projects that benefit newborns ranked by value of additional records identified.

<p>?, single character wildcard.</p><p>_, used to highlight the presence of a blank character.</p

Estimates for the value of aid benefitting newborns in context.

<p>The figure presents the same data as in <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001332#pmed-1001332-g001" target="_blank">Figure 1</a> except in that it excludes the estimates of aid to the health, population, and humanitarian sectors as a whole, and is on a 5-fold smaller scale to enable closer examination of estimates specific to newborns and their relationship to estimates of aid for MNH and MNCH. DAH, development assistance for health.</p

An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria-2

Malarials and antibiotics. Even with a very conservative estimate of the potential harm of treatment, the HRP2 test maintains an advantage across all prevalences. PT – presumptive treatment<p><b>Copyright information:</b></p><p>Taken from "An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria"</p><p>http://www.malariajournal.com/content/7/1/21</p><p>Malaria Journal 2008;7():21-21.</p><p>Published online 28 Jan 2008</p><p>PMCID:PMC2266929.</p><p></p